相关实验视频
Updated: Jun 30, 2025
07:27
Olfactory Assays for Mouse Models of Neurodegenerative Disease
Published on: August 25, 2014
22.0K
越南气味识别测试在帕金森病的诊断价值
Thuong Huyen Thi Dang1, Tai Ngoc Tran1, Frank Xing2
1Movement Disorder Unit, Neurology Department, University Medical Center HCMC, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam.
Journal of the neurological sciences
|March 24, 2024
概括
越南气味识别测试 (VSIT) 显示在越南诊断帕金森病 (PD) 的准确性很高. 这种嗅觉测试可以帮助临床医生改善PD诊断,无论疾病的持续时间或严重程度如何.
科学领域:
- 神经学 神经学
- 嗅觉功能障碍 嗅觉功能障碍
- 诊断工具 诊断工具 诊断工具
背景情况:
- 越南嗅觉识别测试 (VSIT) 在越南被验证用于嗅觉功能障碍.
- 它在诊断帕金森病 (PD) 的实用性仍未确立.
研究的目的:
- 评估VSIT在越南人口中诊断PD的有效性.
- 将VSIT的诊断性能与PD的简短嗅觉识别测试 (BSIT) 进行比较.
主要方法:
- 一项病例控制研究涉及218名非痴呆PD患者和218名年龄和性别匹配的健康对照 (HC).
- 参与者通过VSIT和BSIT进行了嗅觉测试.
- 统计分析比较了VSIT和BSIT在区分PD和HC方面的表现.
主要成果:
- 与HC相比,VSIT在PD患者中显示得分明显较低 (中位数为5比9,P<0.0001).
- 对于PD诊断,VSIT的灵敏度 (84.4%) 和特异性 (86.2%) 比BSIT (分别为81.7%和69.3%) 更高.
- VSIT (0.909) 的曲线下的面积 (AUC) 优于BSIT (0.818).
结论:
- 在越南,VSIT是支持PD诊断的有价值的辅助工具.
- 在PD中嗅觉功能障碍与疾病持续时间或严重程度无关.
- 实施VSIT可以提高临床PD诊断的准确性.
相关概念视频
01:24Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
01:15Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541